Document is current
Any future updates will be listed below
-
Authors
Zamecnik, Colin R. https://orcid.org/0000-0002-9477-1388
Sowa, Gavin M. https://orcid.org/0000-0002-2089-8116
Abdelhak, Ahmed
Dandekar, Ravi
Bair, Rebecca D.
Wade, Kristen J.
Bartley, Christopher M. https://orcid.org/0000-0002-1391-4130
Kizer, Kerry
Augusto, Danillo G.
Tubati, Asritha
Gomez, Refujia
Fouassier, Camille
Gerungan, Chloe
Caspar, Colette M.
Alexander, Jessica
Wapniarski, Anne E.
Loudermilk, Rita P. https://orcid.org/0000-0001-9970-5112
Eggers, Erica L.
Zorn, Kelsey C. https://orcid.org/0000-0003-1227-2137
Ananth, Kirtana
Jabassini, Nora
Mann, Sabrina A.
Ragan, Nicholas R.
Santaniello, Adam
Henry, Roland G.
Baranzini, Sergio E. https://orcid.org/0000-0003-0067-194X
Zamvil, Scott S. https://orcid.org/0000-0003-2720-9915
Sabatino, Joseph J. Jr. https://orcid.org/0000-0002-6804-7441
Bove, Riley M. https://orcid.org/0000-0002-2034-8800
Guo, Chu-Yueh
Gelfand, Jeffrey M.
Cuneo, Richard
von Büdingen, H.-Christian
Oksenberg, Jorge R.
Cree, Bruce A. C.
Hollenbach, Jill A. https://orcid.org/0000-0001-6572-7962
Green, Ari J.
Hauser, Stephen L. https://orcid.org/0000-0002-4932-4001
Wallin, Mitchell T.
DeRisi, Joseph L.
Wilson, Michael R. https://orcid.org/0000-0002-8705-5084
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R35NS122073, R35NS122073, R35NS122073)
National Multiple Sclerosis Society (RFA-2104-37504, RFA-2104-37504, RFA-2104-37504, RFA-2104-37504, RFA-2104-3747, RFA-2104-37504, RFA-2104-37504)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI158861, R01AI158861)
- License Information
-
More Information
Article History
Received: 18 April 2023
Accepted: 21 March 2024
First Online: 19 April 2024
Competing interests
: M.R.W. receives unrelated research grant funding from Roche/Genentech and Novartis and has received speaking honoraria from Genentech, Takeda, WebMD and Novartis. M.R.W. and J.L.D. receive licensing fees from CDI Labs. C.M.B. serves as a paid consultant for the Neuroimmune Foundation. J.J.S. has unrelated research grant funding from Roche/Genentech and Novartis and advisory board honoraria from IgM Biosciences. C.-Y.G. has received financial compensation from serving on advisory boards for Genentech and Horizon. R.G.H. has unrelated research funding from Roche/Genentech and Atara Bio; consulting fees from Roche/Genentech, Novartis and QIA Consulting; and discussion leader fees from Sanofi/Genzyme. The remaining authors declare no competing interests.
